Abeona Therapeutics Inc vs Victoria's Secret & Co — how do they compare? Abeona Therapeutics Inc trades at $7.45 (market cap $421.19M), while Victoria's Secret & Co trades at $94.14 (market cap $7.48B). The key difference: Victoria's Secret & Co is far larger — about 17.8× Abeona Therapeutics Inc's market cap. Which is the better fit depends on your goals.
| ABEO | VSXY | |
|---|---|---|
Market Cap | $421.19M | $7.48B |
Sector | Health | Consumer Cyclical |
52-Week High | $7.45 | $99.97 |
52-Week Low | $4.17 | $21.34 |
Enterprise Value | $276.10M | $10.13B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Victoria's Secret (VSXY) trades at $99.97, up 1.45% today and near its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive earnings surprises in three consecutive quarters. Revenue remains stable at $6.23B for 2025, while net income improved to $165M. Analyst consensus is bullish with 55.6% buy ratings and a $110 high price target, supported by recent international expansion success in China and Europe.
VSXY presents growth potential through international expansion and data-driven marketing, but faces valuation concerns with a P/E of 37.5 and competitive retail pressures. The stock's current price exceeds the consensus target, suggesting near-term consolidation risk despite positive technical momentum and improving fundamentals.
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →